MEI Pharma, Inc.·4

Jul 3, 3:36 PM ET

Mass Robert D. 4

4 · MEI Pharma, Inc. · Filed Jul 3, 2019

Insider Transaction Report

Form 4
Period: 2019-07-01
Mass Robert D.
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-07-01+230,000230,000 total
    Exercise: $2.52Exp: 2029-07-01Common Stock (230,000 underlying)
Footnotes (1)
  • [F1]One-quarter of such Options shall vest on July 1, 2020 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION